Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|March 1, 2004
- Volume 0 0
Sodium Nitrite Injection
Advertisement
Hope Pharmaceuticals (Scottsdale,Ariz) recently announced the release ofSodium Nitrite Injection USP 3% in singledosevials. This product is indicated for thetreatment of cyanide poisoning. It is a primarycomponent of the Cyanide AntidoteKit, which is used by hospitals and publicsafety authorities for emergency preparedness.Cyanide inhalation can causesevere toxic effects and death within minutesto hours. Prompt treatment is criticalfor patient survival. The new vials facilitaterapid administration during an emergency.For more information, visitwww.hopepharm.com.
Articles in this issue
over 22 years ago
Interface Speeds Up Prescription Fillingover 22 years ago
New Technologies Top Surveyover 22 years ago
Partnership Addresses Packaging Solutionsover 22 years ago
PDX Software Gets High Marksover 22 years ago
Polar Powder Cold Pak with Magnetic Therapyover 22 years ago
Seal•ONover 22 years ago
SaltAire Sinus Reliefover 22 years ago
Zim's Crack Creme Hand Sanitizerover 22 years ago
CoroWise Plant Sterolsover 22 years ago
CulturelleAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
5